Angiodynamics To Realize Independence From E-Z-Em Through IPO

Angiodynamics asserts that its focus on peripheral vascular disease (PVD) and its broad product line will enable the firm to hold its own against larger competitors once it goes public

More from Archive

More from Medtech Insight